| Zhang, Zhenyu |
NCT05469685: Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication |
|
|
| Completed | 4 | 914 | RoW | Vonoprazan, Amoxicillin | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 08/23 | 09/23 | | |
NCT06139744: Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS |
|
|
| Not yet recruiting | 4 | 150 | RoW | DAO supplement, PEA SPROUT DEHYDRATED POWDER, Placebo | Nanjing First Hospital, Nanjing Medical University | Irritable Bowel Syndrome (IBS) | 08/24 | 11/24 | | |
NCT05649540: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori |
|
|
| Active, not recruiting | 4 | 900 | RoW | Vonoprazan, Amoxicillin | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 12/24 | 12/24 | | |
NCT05658055: The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication |
|
|
| Not yet recruiting | 4 | 100 | RoW | Vonoprazan, Amoxicillin, probiotics | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection, Infections, Intestinal Bacteria Flora Disturbance | 12/23 | 12/23 | | |
| Not yet recruiting | 4 | 268 | NA | Keverprazan, Potassium-competitive acid blocker, Amoxicillin, Antibiotic for H. pylori eradication | Nanjing First Hospital, Nanjing Medical University | H. Pylori Infection | 12/24 | 02/25 | | |
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis |
|
|
| Recruiting | 3 | 368 | Europe, US, RoW | SHR0302, Placebo | Reistone Biopharma Company Limited, Reistone Biopharma Company Limited | Ulcerative Colitis | 10/24 | 03/25 | | |
NCT04531475: Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis |
|
|
| Recruiting | 2 | 90 | RoW | X842, Undecided, X842 Placebo, Lansoprazole, Lansoprazole Placebo | Jiangsu Sinorda Biomedicine Co., Ltd | Reflux Esophagitis | 10/20 | 12/20 | | |
NCT05461508: Fucoidan Assisted Eradication of Helicobacter Pylori |
|
|
| Recruiting | 1/2 | 60 | RoW | Amoxicillin combined with vonoprazan and fucoidan, Amoxicillin combined with vonoprazan | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection, Intestinal Bacteria Flora Disturbance | 06/24 | 07/24 | | |
NCT04220424: Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis |
|
|
| Recruiting | N/A | 500 | RoW | MR and Histopathology images based prediction of molecular pathology and patient survival | The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University | Glioma | 01/22 | 03/22 | | |
NCT05654857: The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu |
|
|
| Recruiting | N/A | 4000 | RoW | PCR test in the stool | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 08/23 | 08/23 | | |
NCT04216550: Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas |
|
|
| Recruiting | N/A | 600 | RoW | Apatinib | The First Affiliated Hospital of Zhengzhou University | Recurrent Glioma | 01/25 | 06/25 | | |
NCT04216537: Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas |
|
|
| Recruiting | N/A | 3000 | RoW | Glioma groups based on molecular pathology or genetic variation | The First Affiliated Hospital of Zhengzhou University | Glioma, Molecular Sequence Variation, Genetic Change | 01/25 | 06/25 | | |
NCT04215211: MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence |
|
|
| Recruiting | N/A | 2500 | RoW | Survival prediction for glioma patients | The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University | Glioma | 01/27 | 06/27 | | |
NCT04217018: MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence |
|
|
| Recruiting | N/A | 3000 | RoW | Prediction of molecular pathology | The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University | Glioma | 01/27 | 06/27 | | |
NCT04217044: Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence |
|
|
| Recruiting | N/A | 3000 | RoW | Histopathology images based prediction of molecular pathology | The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University | Glioma | 01/27 | 06/27 | | |
NCT04215224: Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence |
|
|
| Recruiting | N/A | 3500 | RoW | Histopathology images based survival prediction for glioma patients | The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University | Glioma | 01/27 | 06/27 | | |
NCT05410652: Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method) |
|
|
| Completed | N/A | 1176 | RoW | Detection of fecal samples with diagnostic kit, Sanger Sequencing group, Bacterial culture and drug sensitivity test of gastric mucosa samples | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection, Helicobacter Pylori gyrA Levofloxacin Resistance Mutation, Fecal Drug Resistance Gene Detection, Helicobacter Pylori Infection, Susceptibility to | 09/23 | 10/23 | | |
